147 related articles for article (PubMed ID: 25909875)
21. Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.
Matsuda M; Kohzuki H; Ishikawa E; Yamamoto T; Akutsu H; Takano S; Mizumoto M; Tsuboi K; Matsumura A
J Clin Neurosci; 2018 Apr; 50():172-176. PubMed ID: 29396060
[TBL] [Abstract][Full Text] [Related]
22. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
Mistry AM; Hale AT; Chambless LB; Weaver KD; Thompson RC; Ihrie RA
J Neurooncol; 2017 Jan; 131(1):125-133. PubMed ID: 27644688
[TBL] [Abstract][Full Text] [Related]
23. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.
Lim DA; Cha S; Mayo MC; Chen MH; Keles E; VandenBerg S; Berger MS
Neuro Oncol; 2007 Oct; 9(4):424-9. PubMed ID: 17622647
[TBL] [Abstract][Full Text] [Related]
24. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study.
Paldor I; Drummond KJ; Kaye AH
J Clin Neurosci; 2016 Dec; 34():117-120. PubMed ID: 27522495
[TBL] [Abstract][Full Text] [Related]
25. What is the role of the subventricular zone in radiotherapy of glioblastoma patients?
Bender K; Träger M; Wahner H; Onken J; Scheel M; Beck M; Ehret F; Budach V; Kaul D
Radiother Oncol; 2021 May; 158():138-145. PubMed ID: 33636228
[TBL] [Abstract][Full Text] [Related]
26. Defining subventricular zone involvement to predict the survival of patients in isocitrate dehydrogenase-wild type glioblastoma: validation in a prospective registry.
Kim JE; Park JE; Park SY; Kim YH; Hong CK; Kim JH; Kim HS
Eur Radiol; 2023 Sep; 33(9):6448-6458. PubMed ID: 37060448
[TBL] [Abstract][Full Text] [Related]
27. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone.
Batista KMP; Eulate-Beramendi SA; Pińa KYÁR; Figueira PR; Canal AF; Chasin JMA; Meilan Á; Ugalde R; Vega IF
Folia Neuropathol; 2017; 55(1):14-22. PubMed ID: 28430288
[No Abstract] [Full Text] [Related]
29. Massive dissemination of adult glioblastomas.
Willard N; Kleinschmidt-DeMasters BK
Clin Neuropathol; 2015; 34(6):330-42. PubMed ID: 26308254
[TBL] [Abstract][Full Text] [Related]
30. Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.
Pirozzi CJ; Carpenter AB; Waitkus MS; Wang CY; Zhu H; Hansen LJ; Chen LH; Greer PK; Feng J; Wang Y; Bock CB; Fan P; Spasojevic I; McLendon RE; Bigner DD; He Y; Yan H
Mol Cancer Res; 2017 May; 15(5):507-520. PubMed ID: 28148827
[No Abstract] [Full Text] [Related]
31. Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement.
Cho N; Wang C; Raymond C; Kaprealian T; Ji M; Salamon N; Pope WB; Nghiemphu PL; Lai A; Cloughesy TF; Ellingson BM
J Neurooncol; 2020 May; 147(3):643-652. PubMed ID: 32239430
[TBL] [Abstract][Full Text] [Related]
32. The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role.
Digregorio M; Coppieters N; Lombard A; Lumapat PN; Scholtes F; Rogister B
Acta Neuropathol Commun; 2021 Apr; 9(1):59. PubMed ID: 33795013
[TBL] [Abstract][Full Text] [Related]
33. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V
J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134
[TBL] [Abstract][Full Text] [Related]
34. Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases.
Kim JH; Bae Kim Y; Han JH; Cho KG; Kim SH; Sheen SS; Lee HW; Jeong SY; Kim BY; Lee KB
Am J Surg Pathol; 2012 Apr; 36(4):620-8. PubMed ID: 22441548
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma Proximity to the Lateral Ventricle Alters Neurogenic Cell Populations of the Subventricular Zone.
Ripari LB; Norton ES; Bodoque-Villar R; Jeanneret S; Lara-Velazquez M; Carrano A; Zarco N; Vazquez-Ramos CA; Quiñones-Hinojosa A; de la Rosa-Prieto C; Guerrero-Cázares H
Front Oncol; 2021; 11():650316. PubMed ID: 34268110
[TBL] [Abstract][Full Text] [Related]
36. Irradiating the Subventricular Zone in Glioblastoma Patients: Is there a Case for a Clinical Trial?
Nourallah B; Digpal R; Jena R; Watts C
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):26-33. PubMed ID: 27729188
[TBL] [Abstract][Full Text] [Related]
37. Cystic glioblastoma: an evaluation of IDH1 status and prognosis.
Sarmiento JM; Nuño M; Ortega A; Mukherjee D; Fan X; Black KL; Patil CG
Neurosurgery; 2014 Jan; 74(1):71-5: discussion 75-6. PubMed ID: 24089051
[TBL] [Abstract][Full Text] [Related]
38. The origin-of-cell harboring cancer-driving mutations in human glioblastoma.
Lee JH; Lee JH
BMB Rep; 2018 Oct; 51(10):481-483. PubMed ID: 30269745
[TBL] [Abstract][Full Text] [Related]
39. Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.
Conroy S; Wagemakers M; Walenkamp AM; Kruyt FA; den Dunnen WF
J Neurooncol; 2017 Jan; 131(1):11-20. PubMed ID: 27633774
[TBL] [Abstract][Full Text] [Related]
40. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
